JPMorgan Chase & Co’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$535K Sell
92,691
-256,326
-73% -$1.48M ﹤0.01% 4028
2025
Q1
$2.3M Sell
349,017
-16,904
-5% -$112K ﹤0.01% 3172
2024
Q4
$3.19M Sell
365,921
-43,320
-11% -$377K ﹤0.01% 3093
2024
Q3
$8M Buy
409,241
+3,092
+0.8% +$60.4K ﹤0.01% 2314
2024
Q2
$8.36M Sell
406,149
-28,247
-7% -$582K ﹤0.01% 2213
2024
Q1
$9.27M Sell
434,396
-38,596
-8% -$823K ﹤0.01% 2173
2023
Q4
$6.8M Sell
472,992
-8,877
-2% -$128K ﹤0.01% 2368
2023
Q3
$4.39M Sell
481,869
-20,582
-4% -$188K ﹤0.01% 2500
2023
Q2
$5.32M Sell
502,451
-10,771
-2% -$114K ﹤0.01% 2450
2023
Q1
$6.28M Sell
513,222
-691
-0.1% -$8.45K ﹤0.01% 2300
2022
Q4
$6.38M Sell
513,913
-34,721
-6% -$431K ﹤0.01% 2216
2022
Q3
$7.5M Sell
548,634
-12,966
-2% -$177K ﹤0.01% 2067
2022
Q2
$10.3M Buy
561,600
+480,848
+595% +$8.81M ﹤0.01% 1861
2022
Q1
$1.3M Sell
80,752
-25,308
-24% -$407K ﹤0.01% 3454
2021
Q4
$1.49M Buy
106,060
+50,547
+91% +$708K ﹤0.01% 3406
2021
Q3
$1.04M Sell
55,513
-1,490
-3% -$27.9K ﹤0.01% 3583
2021
Q2
$1.19M Buy
57,003
+3,477
+6% +$72.5K ﹤0.01% 3541
2021
Q1
$1.51M Sell
53,526
-35,123
-40% -$993K ﹤0.01% 3390
2020
Q4
$2.9M Buy
88,649
+50,549
+133% +$1.65M ﹤0.01% 2750
2020
Q3
$1.16M Buy
38,100
+327
+0.9% +$9.99K ﹤0.01% 3023
2020
Q2
$616K Buy
37,773
+4,162
+12% +$67.9K ﹤0.01% 3220
2020
Q1
$335K Sell
33,611
-26,267
-44% -$262K ﹤0.01% 3490
2019
Q4
$823K Buy
59,878
+22,577
+61% +$310K ﹤0.01% 3185
2019
Q3
$566K Buy
37,301
+3,890
+12% +$59K ﹤0.01% 3295
2019
Q2
$661K Buy
33,411
+26,508
+384% +$524K ﹤0.01% 3241
2019
Q1
$115K Sell
6,903
-325
-4% -$5.41K ﹤0.01% 3962
2018
Q4
$101K Buy
7,228
+675
+10% +$9.43K ﹤0.01% 4042
2018
Q3
$115K Buy
6,553
+1,506
+30% +$26.4K ﹤0.01% 4062
2018
Q2
$92K Buy
5,047
+715
+17% +$13K ﹤0.01% 4109
2018
Q1
$81K Sell
4,332
-723
-14% -$13.5K ﹤0.01% 4000
2017
Q4
$78K Sell
5,055
-50,416
-91% -$778K ﹤0.01% 3992
2017
Q3
$802K Buy
+55,471
New +$802K ﹤0.01% 3019